The I0328000 product is an analytical standard supplied by the EP. It is in powder form. Alternatively, product I9890 (also in powder form) is a research-grade option. Neither of these products would be suitable for human use and are intended for laboratory research only. See the link below to the general research-grade product:
https://www.sigmaaldrich.com/product/sigma/i9890
I0328000
Iobenguane sulfate
European Pharmacopoeia (EP) Reference Standard
Sinónimos:
m-Iodobenzylguanidine hemisulfate salt, MIBG
Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Seleccione un Tamaño
25 MG
132,00 €
132,00 €
Póngase en contacto con nuestro Servicio de Atención al Cliente para disponibilidad
Solicitar un pedido a granel
Seleccione un Tamaño
Cambiar Vistas
25 MG
132,00 €
About This Item
Fórmula lineal:
C8H10IN3 · 1/2H2SO4
Número de CAS:
Peso molecular:
324.13
Número MDL:
Código UNSPSC:
41116107
ID de la sustancia en PubChem:
NACRES:
NA.24
132,00 €
Póngase en contacto con nuestro Servicio de Atención al Cliente para disponibilidad
Solicitar un pedido a granel
Productos recomendados
grado
pharmaceutical primary standard
familia API
iobenguane
fabricante / nombre comercial
EDQM
aplicaciones
pharmaceutical (small molecule)
Formato
neat
temp. de almacenamiento
2-8°C
cadena SMILES
OS(O)(=O)=O.NC(=N)NCc1cccc(I)c1.NC(=N)NCc2cccc(I)c2
InChI
1S/2C8H10IN3.H2O4S/c2*9-7-3-1-2-6(4-7)5-12-8(10)11;1-5(2,3)4/h2*1-4H,5H2,(H4,10,11,12);(H2,1,2,3,4)
Clave InChI
XNACDNPGABUBFR-UHFFFAOYSA-N
¿Está buscando productos similares? Visita Guía de comparación de productos
Descripción general
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
Aplicación
Iobenguane sulfate EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
Envase
The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
Otras notas
Sales restrictions may apply.
Código de clase de almacenamiento
11 - Combustible Solids
Clase de riesgo para el agua (WGK)
WGK 3
Punto de inflamabilidad (°F)
Not applicable
Punto de inflamabilidad (°C)
Not applicable
Elija entre una de las versiones más recientes:
Certificados de análisis (COA)
Lot/Batch Number
It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.
Si necesita más asistencia, póngase en contacto con Atención al cliente
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Radioiodinated metaiodobenzylguanidine (MIBG): radiochemistry, biology, and pharmacology.
Vallabhajosula S and Nikolopoulou A
Seminars in Nuclear Medicine, 41(5), 324-333 (2011)
Yan Su et al.
International journal of molecular medicine, 34(3), 842-848 (2014-06-28)
The aim of the present study was to investigate the effects of meta-iodobenzylguanidine (MIBG) on the invasive properties of hepatocellular carcinoma (HCC) cells and examine whether these effects are due to the ability of MIBG to inhibit arginine-specific mono-ADP-ribosylation. Samples
Shih-ying Huang et al.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging, 17(2), 284-294 (2014-08-26)
Iodine-131-m-iodobenzylguanidine ([(131)I]mIBG)-targeted radionuclide therapy (TRT) is a standard treatment for recurrent or refractory neuroblastoma with response rates of 30-40 %. The aim of this study is to demonstrate patient-specific dosimetry using quantitative [(124)I]mIBG positron emission tomography/X-ray computed tomography (PET/CT) imaging
Lang Rao et al.
EMBO reports, 22(2), e50613-e50613 (2020-12-22)
One major factor that contributes to the virulence of Pseudomonas aeruginosa is its ability to reside and replicate unchallenged inside airway epithelial cells. The mechanism by which P. aeruginosa escapes destruction by intracellular host defense mechanisms, such as autophagy, is not
Shohei Shinozaki et al.
Science signaling, 7(351), ra106-ra106 (2014-11-13)
Inflammation increases the abundance of inducible nitric oxide synthase (iNOS), leading to enhanced production of nitric oxide (NO), which can modify proteins by S-nitrosylation. Enhanced NO production increases the activities of the transcription factors p53 and nuclear factor κB (NF-κB)
-
Hi, I am looking for MIBG solution with non-radioactive iodine solution which can be used for research purposes in CT scans. Could you suggest any solution? Thanks a lot.
1 respuesta-
¿Le ha resultado útil?
-
Filtros activos
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico
